Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:380227rdf:typepubmed:Citationlld:pubmed
pubmed-article:380227lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:380227lifeskim:mentionsumls-concept:C0600139lld:lifeskim
pubmed-article:380227lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:380227lifeskim:mentionsumls-concept:C0205265lld:lifeskim
pubmed-article:380227lifeskim:mentionsumls-concept:C1555582lld:lifeskim
pubmed-article:380227lifeskim:mentionsumls-concept:C0059716lld:lifeskim
pubmed-article:380227pubmed:issue3lld:pubmed
pubmed-article:380227pubmed:dateCreated1979-9-17lld:pubmed
pubmed-article:380227pubmed:abstractTextEthinylestradiol sulphate (J 96) is a depot estrogen which in a dosage of 2 mg per week has clearly antigonadotropic effects and evokes a suppression of the free testosterone in bilaterally orchiectomized patients with carcinoma of the prostate. The good compatibility in oral application and the possibility for the controlled intake recommend its use for the long-term therapy of the carcinoma of the prostate.lld:pubmed
pubmed-article:380227pubmed:languagegerlld:pubmed
pubmed-article:380227pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:380227pubmed:citationSubsetIMlld:pubmed
pubmed-article:380227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:380227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:380227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:380227pubmed:statusMEDLINElld:pubmed
pubmed-article:380227pubmed:monthMarlld:pubmed
pubmed-article:380227pubmed:issn0044-3611lld:pubmed
pubmed-article:380227pubmed:authorpubmed-author:DörnerGGlld:pubmed
pubmed-article:380227pubmed:authorpubmed-author:StahlFFlld:pubmed
pubmed-article:380227pubmed:authorpubmed-author:RohdeWWlld:pubmed
pubmed-article:380227pubmed:authorpubmed-author:SchnorrDDlld:pubmed
pubmed-article:380227pubmed:authorpubmed-author:GuddatH MHMlld:pubmed
pubmed-article:380227pubmed:issnTypePrintlld:pubmed
pubmed-article:380227pubmed:volume72lld:pubmed
pubmed-article:380227pubmed:ownerNLMlld:pubmed
pubmed-article:380227pubmed:authorsCompleteYlld:pubmed
pubmed-article:380227pubmed:pagination153-7lld:pubmed
pubmed-article:380227pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-H...lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-C...lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-D...lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-P...lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-M...lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-C...lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-E...lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-D...lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-T...lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-D...lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-C...lld:pubmed
pubmed-article:380227pubmed:meshHeadingpubmed-meshheading:380227-D...lld:pubmed
pubmed-article:380227pubmed:year1979lld:pubmed
pubmed-article:380227pubmed:articleTitle[Initial experience with ethinyl estradiol sulfonate (J 96) in the therapy of prostate carcinoma].lld:pubmed
pubmed-article:380227pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:380227pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:380227pubmed:publicationTypeEnglish Abstractlld:pubmed